SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008418
Filing Date
2022-05-12
Accepted
2022-05-12 07:00:58
Documents
45
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mist-20220331x10q.htm   iXBRL 10-Q 966184
2 EX-31.1 mist-20220331xex31d1.htm EX-31.1 12311
3 EX-31.2 mist-20220331xex31d2.htm EX-31.2 12462
4 EX-32.1 mist-20220331xex32d1.htm EX-32.1 9985
  Complete submission text file 0001558370-22-008418.txt   3881892

Data Files

Seq Description Document Type Size
5 EX-101.SCH mist-20220331.xsd EX-101.SCH 24486
6 EX-101.CAL mist-20220331_cal.xml EX-101.CAL 25726
7 EX-101.DEF mist-20220331_def.xml EX-101.DEF 85755
8 EX-101.LAB mist-20220331_lab.xml EX-101.LAB 234832
9 EX-101.PRE mist-20220331_pre.xml EX-101.PRE 169894
39 EXTRACTED XBRL INSTANCE DOCUMENT mist-20220331x10q_htm.xml XML 718154
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38899 | Film No.: 22915641
SIC: 2834 Pharmaceutical Preparations